# BELIPHARM

> Besloten Vennootschap founded in 2006, groothandel in farmaceutische en medische artikelen, with its seat in Leuven.

This text is the Markdown version of https://firmatlas.be/en/0884446592-belipharm.

## In brief

BELIPHARM (besloten vennootschap) is an active company registered in 3000 Leuven, enterprise number 0884.446.592. Its main activity is groothandel in farmaceutische en medische artikelen (NACE 46460). The company has existed since 4 October 2006. At the check of 13 November 2026, it was registered on Peppol, the e-invoicing network. The KBO lists 1 establishment unit.

## Identity

- **Enterprise no.:** 0884.446.592
- **VAT number:** BE0884446592 (not yet confirmed by VIES)
- **Legal form:** Besloten Vennootschap (registered as Besloten vennootschap met beperkte aansprakelijkheid)
- **Legal situation:** No bankruptcy or liquidation
- **Start date:** 4 October 2006 (20 years)
- **EUID:** BEKBOBCE.0884.446.592 (European unique identifier)

## Seat and activity

- **Seat:** Herestraat 13 (3000 Leuven)
- **Main activity:** [Groothandel in farmaceutische en medische artikelen](https://firmatlas.be/en/activity/46460-groothandel-in-farmaceutische-en-medische-artikelen) (NACE 46460)
- **Establishments:** [1 establishment](https://firmatlas.be/en/0884446592-belipharm/establishments)
- **E-invoicing:** Receives invoices and credit notes (0208 · 13 November 2026)

## Activities

- 46460 Groothandel in farmaceutische en medische artikelen (main activity)
- 46450 Groothandel in parfumerieën en cosmetica
- 46900 Niet-gespecialiseerde groothandel

## Questions about BELIPHARM

### Where is BELIPHARM located?

The registered seat of BELIPHARM is at Herestraat 13, 3000 Leuven. BELIPHARM has 1 establishment unit in the KBO.

## Sources

- KBO open data: 17 November 2026
- Peppol: 13 November 2026

---

Source: KBO/BCE open data of the FPS Economy, SMEs, Self-employed and Energy, with VIES, Peppol and KBO Public Search added, each with the date of its check. Firmatlas is not affiliated with the FPS Economy.
